Cloma Pharma Methyldrene EPH powder 270 g – product image

Product guide · Restricted substance

Cloma Pharma Methyldrene EPH powder 270 g

Cloma Pharma

Stimulant formula from Cloma Pharma, 270 g of powder. This guide sets out what the manufacturer states about the composition of Cloma Pharma Methyldrene EPH powder 270 g, what independent research says about its main ingredients, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.

Educational guide · Sources checked 4 November 2026 · 17 references

Back to the product
Named ingredients
4
Amounts stated
1 of 4
Status
Restricted substance
Evidence summaries
4

Overview

Manufacturer information

Ingredients & composition

Manufacturer information
IngredientAmount
Ephedra nevadensis extract25 mg per serving
Yohimbine HClNot stated
CreatineNot stated
Citrulline malateNot stated

The manufacturer does not state the amount of 3 of the 4 ingredients. Without amounts, the research summarised in this guide cannot be related to this product's dose.

Scientific background

Independent research

Ephedra and ephedrine

Ephedra (Ephedra sinica, ma huang) contains ephedrine alkaloids, which stimulate the sympathetic nervous system. Ephedrine is also a licensed medicine in some indications1.

Yohimbine (yohimbe bark, rauwolscine)

Yohimbine is an alkaloid from the bark of the African tree Pausinystalia yohimbe. It blocks α2-adrenergic receptors, which increases noradrenaline release. Rauwolscine (alpha-yohimbine) is a closely related alkaloid.

Creatine monohydrate

Creatine is a compound the body makes from the amino acids arginine, glycine and methionine, and it is also eaten in meat and fish. Most of it is stored in skeletal muscle, where phosphocreatine helps regenerate ATP, the immediate energy source for short, intense muscle contractions2.

Creatine monohydrate is the form used in most of the published research23.

L-citrulline and citrulline malate

L-citrulline is an amino acid that the body converts to arginine, a precursor of nitric oxide, which widens blood vessels. Citrulline malate combines citrulline with malic acid4.

Research evidence

Independent research

Ephedra and ephedrine

A meta-analysis of clinical trials found that ephedra or ephedrine produced modest short-term weight loss of about 0.9 kg a month more than placebo, with no data on long-term weight loss and insufficient evidence for athletic performance1.

Yohimbine (yohimbe bark, rauwolscine)

A small trial in professional soccer players found reduced body fat with yohimbine but no change in body mass, muscle mass or performance5. Larger, independent trials are lacking.

Creatine monohydrate

Supplementation raises muscle creatine stores. The International Society of Sports Nutrition position stand concludes that creatine monohydrate is an effective ergogenic supplement for increasing high-intensity exercise capacity and lean body mass during training2.

A meta-analysis of randomised trials found improved upper-limb strength when creatine was combined with resistance training6, and a meta-analysis in older adults found greater gains in muscle mass and strength with creatine plus resistance training than with training alone7.

In the EU, the European Food Safety Authority (EFSA) assessed the evidence and found a cause-and-effect relationship between a daily intake of 3 g of creatine and increased physical performance in successive bursts of short-term, high-intensity exercise8. That claim is authorised under Regulation (EU) No 432/20129, and a second claim on muscle strength in adults over 55 who do resistance training under Regulation (EU) 2017/67210.

L-citrulline and citrulline malate

A review of human studies found that citrulline supplementation raises plasma arginine, and that several studies report improved exercise performance or recovery, but the results are inconsistent4.

Evidence limitations

Independent research

This product does not state all ingredient amounts, so the doses used in research cannot be compared with what one serving provides.

The studies summarised in this guide examined single ingredients. No published study has tested this product or this combination of ingredients.

Ephedra and ephedrine

The trials were short and did not assess long-term outcomes1.

Yohimbine (yohimbe bark, rauwolscine)

Evidence for fat loss or performance is limited to small studies. Supplement labels are often inaccurate: of 49 US yohimbine supplements tested, only 2 gave accurate information on both the quantity and the known adverse effects11.

Creatine monohydrate

The benefits shown are for repeated short, high-intensity efforts and for training adaptations. They do not extend to endurance performance, which EFSA did not find to be substantiated8.

Individual responses vary, and many trials are small and short2.

L-citrulline and citrulline malate

Studies differ in dose, form (citrulline or citrulline malate, often with an unverified ratio) and exercise test, and many are small. The mechanism behind any performance effect is not established4.

Safety & potential risks

Independent research

Ephedra and ephedrine

Use of ephedra or ephedrine with caffeine was associated with an increased risk of psychiatric, autonomic and gastrointestinal symptoms and heart palpitations1.

Yohimbine (yohimbe bark, rauwolscine)

A review of poison-centre cases found that adverse events with yohimbine products had more serious outcomes than average exposures, including rapid heart rate, anxiety, high blood pressure and agitation12. People with heart conditions, high blood pressure, anxiety disorders or taking antidepressants should not use yohimbine.

Creatine monohydrate

Reviews of the clinical literature report no consistent adverse effects of creatine monohydrate in healthy people at commonly studied intakes. A meta-analysis found no significant effect on markers of kidney function133.

People with kidney disease, and anyone taking medication, should speak to a doctor before using creatine. A small rise in blood creatinine is expected with supplementation and can be misread as reduced kidney function3.

L-citrulline and citrulline malate

Citrulline is generally well tolerated in the doses studied. Digestive discomfort has been reported, and people taking blood-pressure or erectile-dysfunction medication should ask a doctor, because citrulline raises arginine and nitric oxide production4.

Regulatory status

GIGACULT product information

Contains Ephedra nevadensis extract. Ephedra species and their preparations are prohibited in foods, including food supplements, in the EU (Regulation (EC) No 1925/2006, Annex III, Part A). Contains yohimbine. Isolated yohimbine is classified as a medicinal substance in several EU member states; its legal status depends on the country of sale.

Regulation and sport

Ephedra and ephedrine

Ephedra species and their preparations are prohibited in foods, including food supplements, in the EU (Regulation (EC) No 1925/2006, Annex III, Part A)14. Ephedrine is prohibited in competition by the World Anti-Doping Agency above a urinary threshold15.

Yohimbine (yohimbe bark, rauwolscine)

Yohimbine is a pharmacologically active substance. Its use in food is regulated under Regulation (EC) No 1925/2006 and national rules14, and several EU Member States treat it as a medicinal substance16.

Creatine monohydrate

Creatine is sold in the EU as a food supplement ingredient under the food supplements framework17. Only the authorised wording of the two creatine health claims may be used, and only at the qualifying intake of 3 g a day910.

L-citrulline and citrulline malate

L-citrulline is used in EU food supplements under national rules. No health claim for citrulline is authorised in the EU9.

Scientific references

  1. Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289:1537-1545. PubMed 12672771
  2. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. PubMed 28615996
  3. Antonio J, Candow DG, Forbes SC, et al. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? J Int Soc Sports Nutr. 2021;18:13. PubMed 33557850
  4. Gonzalez AM, Trexler ET. Effects of citrulline supplementation on exercise performance in humans: a review of the current literature. J Strength Cond Res. 2020;34:1480-1495. PubMed 31977835
  5. Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer players. Res Sports Med. 2006;14:289-299. PubMed 17214405
  6. Lanhers C, Pereira B, Naughton G, et al. Creatine supplementation and upper limb strength performance: a systematic review and meta-analysis. Sports Med. 2017;47:163-173. PubMed 27328852
  7. Devries MC, Phillips SM. Creatine supplementation during resistance training in older adults: a meta-analysis. Med Sci Sports Exerc. 2014;46:1194-1203. PubMed 24576864
  8. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the substantiation of health claims related to creatine and increase in physical performance during short-term, high intensity, repeated exercise bouts. EFSA Journal. 2011;9(7):2303. DOI 10.2903/j.efsa.2011.2303
  9. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union. Source
  10. Commission Implementing Regulation (EU) 2017/672 authorising a health claim made on foods (creatine and muscle strength in adults over 55). Official Journal of the European Union. Source
  11. Cohen PA, Wang YH, Maller G, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 2016;8:357-369. PubMed 26391406
  12. Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother. 2010;44:1022-1029. PubMed 20442348
  13. de Souza E Silva A, Pertille A, Reis Barbosa CG, et al. Effects of creatine supplementation on renal function: a systematic review and meta-analysis. J Ren Nutr. 2019;29:480-489. PubMed 31375416
  14. Regulation (EC) No 1925/2006 on the addition of vitamins and minerals and of certain other substances to foods. Official Journal of the European Union. Source
  15. World Anti-Doping Agency. The Prohibited List (current edition). Source
  16. Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
  17. Directive 2002/46/EC on the approximation of the laws of the Member States relating to food supplements. Official Journal of the European Union. Source

Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product

Cloma Pharma Methyldrene EPH powder 270 g

€49,90

View product